For: | Tajiri K, Shimizu Y. New horizon for radical cure of chronic hepatitis B virus infection. World J Hepatol 2016; 8(21): 863-873 [PMID: 27478536 DOI: 10.4254/wjh.v8.i21.863] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i21/863.htm |
Number | Citing Articles |
1 |
A.J. Uriel, P. Martin. Reference Module in Biomedical Sciences. 2019; doi: 10.1016/B978-0-12-801238-3.02508-3
|
2 |
Devesh Tewari, Andrei Mocan, Emil D. Parvanov, Archana N. Sah, Seyed M. Nabavi, Lukasz Huminiecki, Zheng Feei Ma, Yeong Yeh Lee, Jarosław O. Horbańczuk, Atanas G. Atanasov. Ethnopharmacological Approaches for Therapy of Jaundice: Part I. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00518
|
3 |
Lesley J. Scott, Henry L. Y. Chan. Tenofovir Alafenamide: A Review in Chronic Hepatitis B. Drugs 2017; 77(9): 1017 doi: 10.1007/s40265-017-0754-9
|
4 |
Pamela Hummert, Teresa L. Parsons, Laura M. Ensign, Thuy Hoang, Mark A. Marzinke. Validation and implementation of liquid chromatographic-mass spectrometric (LC–MS) methods for the quantification of tenofovir prodrugs. Journal of Pharmaceutical and Biomedical Analysis 2018; 152: 248 doi: 10.1016/j.jpba.2018.02.011
|
5 |
Young Kang, Siddhartha Rawat, Nicholas Duchemin, Michael Bouchard, Moses Noh. Human Liver Sinusoid on a Chip for Hepatitis B Virus Replication Study. Micromachines 2017; 8(1): 27 doi: 10.3390/mi8010027
|
6 |
Yasmin Badshah, Maria Shabbir, Sameen Zafar, Uzma Mussarat, Aamer Ikram, Sumbal Javed, Hashaam Akhtar. Impact of IL-12B Genetic Variants on Antiviral Treatment Response among Hepatitis B Patients in Pakistan. Livers 2023; 3(3): 494 doi: 10.3390/livers3030034
|
7 |
Ji Yu, Haiyong Jia, Xiaowei Guo, Samuel Desta, Shuo Zhang, Jian Zhang, Xiao Ding, Xiaohong Liang, Xinyong Liu, Peng Zhan. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non‐nucleoside hepatitis B virus inhibitors by exploring the solvent‐exposed region. Chemical Biology & Drug Design 2020; 95(6): 567 doi: 10.1111/cbdd.13512
|
8 |
Erik De Clercq. Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infections. Biochemical Pharmacology 2018; 153: 2 doi: 10.1016/j.bcp.2017.11.023
|
9 |
L. Salleras. Veinticinco años de vacunación sistemática frente a la hepatitis B de los preadolescentes en Cataluña. Vacunas 2017; 18(2): 59 doi: 10.1016/j.vacun.2017.09.001
|
10 |
L. Salleras. 25 years of systematic hepatitis B vaccination of pre-adolescents in Catalonia. Vacunas (English Edition) 2017; 18(2): 59 doi: 10.1016/j.vacune.2017.11.005
|
11 |
Magda Rybicka, Krzysztof Piotr Bielawski. Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus Infection. Microorganisms 2020; 8(9): 1416 doi: 10.3390/microorganisms8091416
|